Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the aorta
- 1 January 1978
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Diagnosis
- Vol. 4 (1), 97-102
- https://doi.org/10.1002/ccd.1810040114
Abstract
Prostaglandin E1 (PGE1) was infused into the pulmonary artery in a 1‐day‐old infant with symptomatic coarctation. Umbilical artery pressure rose from 50/40 mm Hg before infusion to 83/48 mm Hg after infusion, indicating significant improvement in lower‐body perfusion. Successful coarctation repair was performed during continued PGE1 infusion. To our knowledge, this is the first reported patient in whom PGE1 has been used for successful emergency palliation of symptomatic coarctation.This publication has 12 references indexed in Scilit:
- The use of prostaglandin E1 in an infant with interruption of the aortic archThe Journal of Pediatrics, 1977
- Ductus Arteriosus Dilatation by Prostaglandin E1 in Infants With Pulmonary AtresiaPediatrics, 1977
- Medical Treatment of the Ductus ArteriosusHospital Practice, 1977
- Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation, 1977
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- Physiological and Pharmacological Roles of ProstaglandinsAnnual Review of Pharmacology, 1975
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975
- Hemodynamic considerations in the development of narrowing of the aortaThe American Journal of Cardiology, 1972
- Circulatory and Respiratory Effects of Different Doses of Prostaglandin E1 in ManActa Physiologica Scandinavica, 1969